Pharmaceutical Statistics
Издатель: Wiley ·
ISSN 15391604 ·
30 статей
-
A Simplified and Flexible Counterfactual Approach to Treatment Switching at a Secondary Baseline in Randomized Trials
Patrick M. Schnell,
Michael Johnson,
Vladimir Svetnik,
Shahrul Mt‐Isa
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-18
-
Bayesian Approaches in Drug Development: Interpreting the 2026 US Food and Drug Administration Draft Guidance for Optimal Dose Finding
Ayon Mukherjee
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-13
-
Improving Safety Reporting: Putting the Question First and Choosing the Right Estimator for the Incidence of Treatment‐Emergent Adverse Events
Stefan Englert,
Zoe Craig,
Nicolas Sauvageot,
Valentine Jehl,
Anirban Mitra,
Jane Gilbert,
Lilla Di Scala,
Leen Slaets
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-13
-
A New Optimal Cut‐Points Selection Method for Diseases With Multiple Ordinal Stages and Its Confidence Interval Estimation
Nan An,
Lili Tian
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-12
-
Advancing Drug Development Through Bayesian Approaches: Insights Drawn From Practical Experience in Pharmaceutical R&D
Telba Irony,
Tobias Mielke,
Fredrik Ohrn,
Vladimir Dragalin
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-11
-
Inverse Probability of Censoring Weights for Single and Competing Events Survival Analyses With Dependent Censoring
Emily C. Zabor,
Anne A. Eaton
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-08
-
Evaluating Early‐Stage Oncology Clinical Trial Designs in the Era of Project Optimus: A Scoping Review
Marie‐Karelle Riviere,
Anaïs Andrillon,
Pavel Mozgunov,
Emma Gerard,
Moreno Ursino
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-06
-
Estimands for Randomized Discontinuation Designs in Oncology
Ayon Mukherjee,
Oleksandr Sverdlov,
Yu Deng
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-11-02
-
Estimation Following Surrogate Based Selection in Multi‐Arm Drop‐The‐Losers Designs
Mojammel Haque Sarkar,
Mohd Arshad,
Masihuddin
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-30
-
An Inverse‐Selection‐Probability Weighted Approach for Real‐World Progression‐Free Survival With Left‐Truncated Clinico‐Genomic Data
Yan Liu,
Seung Won Hyun,
Chithra Sangli,
Kyle Beauchamp,
Farahnaz Islam,
Dongho Shin
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-28
-
Estimation of Treatment Effect in Clinical Trials of Continuous Endpoints With Retrieved Dropouts
Myeongjong Kang,
Sangyoon Yi
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-26
-
Unified Implementation and Comparison of Bayesian Shrinkage Methods for Treatment Effect Estimation in Subgroups
Marcel Wolbers,
Miriam Pedrera Gómez,
Alex Ocampo,
Isaac Gravestock
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-22
-
Confidence Intervals for the MADET Index and Its Corresponding Classification Thresholds Using Generalized Pivotal Quantities
Fernando J. Nhampossa,
Elisa M. Molanes‐López,
Emilio Letón
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-21
-
Joint Model for Assessing the Effect of Frailty and Longitudinal Measures in Time‐To‐Event Outcome
Anand Hari,
Divya Dennis,
Jagathnath Krishna Kumara Pillai Mohanan Nair,
Aleyamma Mathew
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-17
-
Variable Selection for the Propensity Score Model: Beyond Main Effects and Linear Relations
Peter C. Austin,
Guy Cafri
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-17
-
Variations of Power Priors in Time‐to‐Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting
Heliang Shi,
Maria Kudela,
Yuxi Zhao,
Margaret Gamalo
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-17
-
Multiple Imputation for Recurrent Events With Off‐Risk Periods
Szilárd Nemes
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-12
-
Power With Confounders in Clinical Trials Using External Controls
Kentaro Kudo,
Tosiya Sato
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-12
-
BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint
Yusuke Tanaka,
Kentaro Takeda,
Ryo Kitabayashi,
Hiroyuki Sato,
Akihiro Hirakawa
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-10-05
-
TITE‐LOCRM12: A Local Continual Reassessment Method for Drug Combination Optimization Based on Late‐Onset Toxicity and Efficacy Outcomes
Li Liu,
Ruitao Lin,
Nolan A. Wages
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-30
-
A Practical Guide to Optimal Adaptive Two‐Stage Designs for Various Endpoint Types
Nico Bruder,
Jan Meis,
Maximilian Pilz,
Meinhard Kieser
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-29
-
BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints
Yike Tang,
Feng Tian,
Xiaochen Zhu,
Guotao Chu,
Liangang Liu,
Hsin‐Ju Hsieh,
Shu‐Pang Huang
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-29
-
On the Conservativeness of Robust Variance Estimators in Propensity Score Weighted Cox Models
Hiroya Morita,
Shunichiro Orihara,
Fumitaka Shimizu,
Masataka Taguri
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-29
-
Testing Risk Difference of Two Proportions for Combined Unilateral and Bilateral Data
Jia Zhou,
Chang‐Xing Ma
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-25
-
Evaluating the Impact of Outcome Delay on the Efficiency of Sample Size Re‐Estimation
Aritra Mukherjee,
Michael J. Grayling,
James M. S. Wason
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-24
-
Bayesian Power‐Based Sample Size Determination for Diagnostic Accuracy Studies
Shunsuke Shiota,
Go Horiguchi,
Akari Naito,
Mitsuko Nakata,
Satoshi Teramukai
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-21
-
A Seamless Phase I/II Design With Randomization for Biomarker‐Guided Oncology Trials
Emily C. Zabor,
Sneha Govande,
Wen Wee Ma,
Brian P. Hobbs
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-21
-
Sensitivity of Responder Effects to Different Thresholds and Control Group Means on Patient‐Reported Outcomes: Varying Group Standard Deviations
Joseph C. Cappelleri,
Jia Ma,
Manuela Di Fusco,
Xiaowu Sun
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-17
-
Issue Information
Pharmaceutical Statistics
· Медицинская фармакология
· 2026-09-17
-
Correction to “The Flaw of Averages: Bayes Factors as Posterior Means of the Likelihood Ratio”
Pharmaceutical Statistics
· Медицинская фармакология
· 2025-03-04